KiDSafe - Improving medication safety for children and adolescents: implementation and evaluation of a new form of care

KiDSafe - Improving medication safety for children and adolescents: implementation and evaluation of a new form of care - KiDSafe

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013924

Enrollment

47400

Registered

2018-06-29

Start date

2018-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality assurance procedure to increase the safety of drug therapy for children and adolescents

Interventions

Group 1: Intervention phase: Use of a digital paediatric drug information system, participation to regular paediatric-pharmacological quality circles, stimulated spontaneous reporting of adverse drug

Eligibility

Sex/Gender

All

Age

No minimum to 17 Years

Inclusion criteria

Inclusion criteria: non-elective admitted patients, who are less than 18 years of age at the time of admission

Exclusion criteria

Exclusion criteria: oncological patients who are hospitalized with suspected ADR/ME and who have been hospitalized in the previous 4 weeks for oncological treatment

Design outcomes

Primary

Measure	Time frame
Incidence of drug-related hospital admissions	—

Secondary

Measure	Time frame
Prescribing and reporting behavior of outpatient doctors	—

Countries

Germany

Contacts

Public ContactAntje Neubert

Universitätsklinikum Erlangen, Kinder- und Jugendklinik

antje.neubert@uk-erlangen.de09131-85-36874

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026